China SXT Pharmaceuticals, Inc. SEC filings

Filings

1. SCHEDULE 13GChina SXT Pharmaceuticals, Inc.SXTC3d

   Orca Capital AG reports 9.9% stake in SXTC

   • 1,112,788 shares beneficially owned
   • 9.9% of class
   • Sole voting and disposition rights

   Orca Capital AG, filed by

2. 6-KChina SXT Pharmaceuticals, Inc.SXTCOct 9

   China SXT raises $12M via stock offering

   • Offering 8M units at $1.50 each
   • Warrants exercisable at $2.75 per share
   • Placement agent fee 7% of gross proceeds
3. 424B5China SXT Pharmaceuticals, Inc.SXTCOct 9

   China SXT Pharmaceuticals offers $9M in shares

   • Up to 8,000,000 units offered
   • Each unit priced at $1.50
   • Total potential proceeds up to $9,000,000
4. 6-KChina SXT Pharmaceuticals, Inc.SXTCOct 8

   China SXT Pharmaceuticals cancels offering

   • Entered into a $3M securities purchase agreement
   • Offering terminated before closing
   • No shares or warrants issued
5. 6-KChina SXT Pharmaceuticals, Inc.SXTCOct 8

   China SXT Pharmaceuticals announces $12M offering

   • Issued 8M Class A shares at $1.50 each
   • Issued 8M warrants with $2.75 exercise price
   • Offering expected to close Oct 9, 2026
6. EFFECTChina SXT Pharmaceuticals, Inc.SXTCSep 17

   Registration declared effective

7. F-3/AChina SXT Pharmaceuticals, Inc.SXTCAug 28

   Securities offering (amended)

8. 6-KChina SXT Pharmaceuticals, Inc.SXTCAug 28

   Foreign issuer report

9. 6-KChina SXT Pharmaceuticals, Inc.SXTCJul 24

   Foreign issuer report

10. 424B5China SXT Pharmaceuticals, Inc.SXTCJul 24

    Securities offering

11. F-3China SXT Pharmaceuticals, Inc.SXTCJul 7

    Securities offering

12. 6-KChina SXT Pharmaceuticals, Inc.SXTCJul 6

    Foreign issuer report

13. 20-FChina SXT Pharmaceuticals, Inc.SXTCJul 1

    Annual report

14. 6-KChina SXT Pharmaceuticals, Inc.SXTCJun 1

    Foreign issuer report

15. 424B5China SXT Pharmaceuticals, Inc.SXTCJun 1

    Securities offering

16. 6-KChina SXT Pharmaceuticals, Inc.SXTCMay 4

    Foreign issuer report

17. 3China SXT Pharmaceuticals, Inc.SXTCApr 27

    7 insider filings

    Xiaodong Sean Pan, new insider at SXTC

    Show all 7

    • 3New insider at SXTCApr 27
    • 3New insider at SXTCApr 27
    • 3New insider at SXTCApr 27
    • 3New insider at SXTCApr 27
    • 3New insider at SXTCApr 27
    • 3New insider at SXTCApr 27
    • 3New insider at SXTCApr 27

    Xiaodong Sean Pan, reporting

18. 424B5China SXT Pharmaceuticals, Inc.SXTCApr 9

    Securities offering

19. 6-KChina SXT Pharmaceuticals, Inc.SXTCApr 9

    Foreign issuer report

20. 6-KChina SXT Pharmaceuticals, Inc.SXTCJan 13

    Foreign issuer report

21. 424B5China SXT Pharmaceuticals, Inc.SXTCJan 12

    Securities offering

22. 6-KChina SXT Pharmaceuticals, Inc.SXTCDec 31, 2025

    Foreign issuer report

23. F-3China SXT Pharmaceuticals, Inc.SXTCNov 10, 2025

    Securities offering

24. POS AMChina SXT Pharmaceuticals, Inc.SXTCNov 10, 2025

    POS AM filing

Older filings on EDGAR